Perry Mark L
- SEC CIK
- 0001190270
No open-market purchases or sales filed in the past year.
Current role at each company
- NVDA NVIDIA CorpDirectoras of Jun 26, 2024
- GBT Global Blood Therapeutics, Inc.Directoras of Oct 6, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Perry Mark L as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
NVDA NVIDIA Corp
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 3, 2024 (view filing) | Apr 2 | 1 day | Perry Mark LDirector | SSale | −7.00K | $887.89 | −$6.22M | −5.7%116.0K after | |
| Feb 27, 2024 (view filing) | Feb 23 | 4 days | Perry Mark LDirector | SSale | −15.0K | $796.45 | −$11.9M | −10.9%123.0K after | |
| Feb 28, 2023 (view filing) | Feb 27 | 1 day | Perry Mark LDirector | SSale | −20.0K | $236.37 | −$4.73M | −12.5%140.0K after | 4 lots |
| Mar 21, 2022 (view filing) | Mar 18 | 3 days | Perry Mark LDirector | SSale | −16.7K | $263.80 | −$4.41M | −59.2%11.5K after | 4 lots |